Given that mammary adipocytes are an important component of the tumor microenvironment in mammary cancers [50], and since leptin is considered to promote breast cancer [19,20], our results suggest the possible utility of targeting mammary ME1 for breast cancer treatment. Here, LEP is linked to neoplasm.